nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—SRC—periosteum—periodontitis	0.00864	0.0223	CbGeAlD
Bosutinib—CSF1R—periosteum—periodontitis	0.00776	0.02	CbGeAlD
Bosutinib—PHKG1—mouth—periodontitis	0.00601	0.0155	CbGeAlD
Bosutinib—PKMYT1—neck—periodontitis	0.00538	0.0139	CbGeAlD
Bosutinib—PLK2—mouth—periodontitis	0.00493	0.0127	CbGeAlD
Bosutinib—EPHA4—tongue—periodontitis	0.00492	0.0127	CbGeAlD
Bosutinib—ULK3—tongue—periodontitis	0.00486	0.0125	CbGeAlD
Bosutinib—CDK2—neck—periodontitis	0.00478	0.0124	CbGeAlD
Bosutinib—EIF2AK1—trigeminal ganglion—periodontitis	0.00439	0.0113	CbGeAlD
Bosutinib—VRK2—trigeminal ganglion—periodontitis	0.00425	0.011	CbGeAlD
Bosutinib—SYK—trigeminal ganglion—periodontitis	0.00417	0.0108	CbGeAlD
Bosutinib—CDK2—trigeminal ganglion—periodontitis	0.00413	0.0107	CbGeAlD
Bosutinib—PTK2—endothelium—periodontitis	0.00412	0.0106	CbGeAlD
Bosutinib—FES—parotid gland—periodontitis	0.00401	0.0104	CbGeAlD
Bosutinib—VRK2—parotid gland—periodontitis	0.00401	0.0104	CbGeAlD
Bosutinib—SIK2—connective tissue—periodontitis	0.00396	0.0102	CbGeAlD
Bosutinib—DMPK—trigeminal ganglion—periodontitis	0.00392	0.0101	CbGeAlD
Bosutinib—WEE1—trigeminal ganglion—periodontitis	0.00392	0.0101	CbGeAlD
Bosutinib—EPHB4—endothelium—periodontitis	0.00375	0.00968	CbGeAlD
Bosutinib—STK25—trigeminal ganglion—periodontitis	0.00374	0.00967	CbGeAlD
Bosutinib—PLK2—trigeminal ganglion—periodontitis	0.00364	0.0094	CbGeAlD
Bosutinib—SRMS—connective tissue—periodontitis	0.0036	0.0093	CbGeAlD
Bosutinib—BMX—epithelium—periodontitis	0.00358	0.00924	CbGeAlD
Bosutinib—STK25—parotid gland—periodontitis	0.00353	0.00912	CbGeAlD
Bosutinib—SYK—connective tissue—periodontitis	0.00346	0.00894	CbGeAlD
Bosutinib—CAMK1D—trigeminal ganglion—periodontitis	0.00344	0.00888	CbGeAlD
Bosutinib—PLK2—parotid gland—periodontitis	0.00343	0.00887	CbGeAlD
Bosutinib—CDK2—connective tissue—periodontitis	0.00343	0.00886	CbGeAlD
Bosutinib—SIK1—mouth—periodontitis	0.00334	0.00863	CbGeAlD
Bosutinib—EPHA4—mouth—periodontitis	0.00331	0.00854	CbGeAlD
Bosutinib—FER—trigeminal ganglion—periodontitis	0.00329	0.0085	CbGeAlD
Bosutinib—EPHA5—trigeminal ganglion—periodontitis	0.00329	0.0085	CbGeAlD
Bosutinib—ERBB3—mouth—periodontitis	0.00328	0.00846	CbGeAlD
Bosutinib—ULK3—mouth—periodontitis	0.00327	0.00844	CbGeAlD
Bosutinib—CDK2—epithelium—periodontitis	0.00326	0.00841	CbGeAlD
Bosutinib—BTK—trigeminal ganglion—periodontitis	0.00321	0.00828	CbGeAlD
Bosutinib—SRC—endothelium—periodontitis	0.00319	0.00823	CbGeAlD
Bosutinib—PTK2—mouth—periodontitis	0.00318	0.00821	CbGeAlD
Bosutinib—MAP2K1—neck—periodontitis	0.00317	0.0082	CbGeAlD
Bosutinib—CSNK1A1—neck—periodontitis	0.00313	0.00809	CbGeAlD
Bosutinib—MAP4K2—trigeminal ganglion—periodontitis	0.00312	0.00805	CbGeAlD
Bosutinib—CLK1—neck—periodontitis	0.00311	0.00804	CbGeAlD
Bosutinib—DMPK—epithelium—periodontitis	0.00309	0.00798	CbGeAlD
Bosutinib—BMP2K—neck—periodontitis	0.00305	0.00789	CbGeAlD
Bosutinib—PLK2—connective tissue—periodontitis	0.00302	0.0078	CbGeAlD
Bosutinib—EPHB3—trigeminal ganglion—periodontitis	0.00292	0.00755	CbGeAlD
Bosutinib—STK4—connective tissue—periodontitis	0.00289	0.00746	CbGeAlD
Bosutinib—MAP4K4—trigeminal ganglion—periodontitis	0.00284	0.00733	CbGeAlD
Bosutinib—BCR—trigeminal ganglion—periodontitis	0.00282	0.00728	CbGeAlD
Bosutinib—NUAK2—trigeminal ganglion—periodontitis	0.00282	0.00728	CbGeAlD
Bosutinib—MAP3K12—trigeminal ganglion—periodontitis	0.0028	0.00722	CbGeAlD
Bosutinib—ALK—connective tissue—periodontitis	0.00273	0.00705	CbGeAlD
Bosutinib—TYRO3—connective tissue—periodontitis	0.00273	0.00705	CbGeAlD
Bosutinib—CSK—trigeminal ganglion—periodontitis	0.00272	0.00703	CbGeAlD
Bosutinib—PTK2—neck—periodontitis	0.00272	0.00702	CbGeAlD
Bosutinib—TBK1—neck—periodontitis	0.00272	0.00702	CbGeAlD
Bosutinib—LYN—connective tissue—periodontitis	0.00272	0.00702	CbGeAlD
Bosutinib—CSNK1A1—trigeminal ganglion—periodontitis	0.0027	0.00698	CbGeAlD
Bosutinib—HCK—trigeminal ganglion—periodontitis	0.00269	0.00694	CbGeAlD
Bosutinib—CLK1—trigeminal ganglion—periodontitis	0.00269	0.00694	CbGeAlD
Bosutinib—BTK—connective tissue—periodontitis	0.00266	0.00687	CbGeAlD
Bosutinib—NUAK2—parotid gland—periodontitis	0.00266	0.00686	CbGeAlD
Bosutinib—BCR—parotid gland—periodontitis	0.00266	0.00686	CbGeAlD
Bosutinib—BMP2K—trigeminal ganglion—periodontitis	0.00264	0.00681	CbGeAlD
Bosutinib—LRRK2—trigeminal ganglion—periodontitis	0.00261	0.00675	CbGeAlD
Bosutinib—RPS6KB1—neck—periodontitis	0.00261	0.00675	CbGeAlD
Bosutinib—CSK—parotid gland—periodontitis	0.00257	0.00663	CbGeAlD
Bosutinib—CSNK1A1—parotid gland—periodontitis	0.00255	0.00659	CbGeAlD
Bosutinib—CLK1—parotid gland—periodontitis	0.00253	0.00655	CbGeAlD
Bosutinib—ROCK1—connective tissue—periodontitis	0.00252	0.0065	CbGeAlD
Bosutinib—CSNK1E—trigeminal ganglion—periodontitis	0.00251	0.00647	CbGeAlD
Bosutinib—IRAK4—trigeminal ganglion—periodontitis	0.00247	0.00637	CbGeAlD
Bosutinib—SIK1—trigeminal ganglion—periodontitis	0.00247	0.00637	CbGeAlD
Bosutinib—BMPR2—connective tissue—periodontitis	0.00245	0.00632	CbGeAlD
Bosutinib—ERBB4—epithelium—periodontitis	0.00242	0.00626	CbGeAlD
Bosutinib—MAP2K2—trigeminal ganglion—periodontitis	0.00241	0.00623	CbGeAlD
Bosutinib—ULK3—trigeminal ganglion—periodontitis	0.00241	0.00623	CbGeAlD
Bosutinib—ROCK1—epithelium—periodontitis	0.00239	0.00618	CbGeAlD
Bosutinib—MAP3K7—trigeminal ganglion—periodontitis	0.00237	0.00613	CbGeAlD
Bosutinib—CSNK1E—parotid gland—periodontitis	0.00236	0.00611	CbGeAlD
Bosutinib—MAP4K4—connective tissue—periodontitis	0.00235	0.00608	CbGeAlD
Bosutinib—TBK1—trigeminal ganglion—periodontitis	0.00235	0.00606	CbGeAlD
Bosutinib—SIK1—parotid gland—periodontitis	0.00233	0.00601	CbGeAlD
Bosutinib—IRAK4—parotid gland—periodontitis	0.00233	0.00601	CbGeAlD
Bosutinib—ULK3—parotid gland—periodontitis	0.00228	0.00588	CbGeAlD
Bosutinib—MAP2K1—connective tissue—periodontitis	0.00227	0.00587	CbGeAlD
Bosutinib—CSK—connective tissue—periodontitis	0.00226	0.00584	CbGeAlD
Bosutinib—RPS6KB1—trigeminal ganglion—periodontitis	0.00226	0.00583	CbGeAlD
Bosutinib—LCK—trigeminal ganglion—periodontitis	0.00224	0.00579	CbGeAlD
Bosutinib—MAP3K7—parotid gland—periodontitis	0.00224	0.00578	CbGeAlD
Bosutinib—AXL—trigeminal ganglion—periodontitis	0.00223	0.00577	CbGeAlD
Bosutinib—CLK1—connective tissue—periodontitis	0.00223	0.00576	CbGeAlD
Bosutinib—TBK1—parotid gland—periodontitis	0.00221	0.00571	CbGeAlD
Bosutinib—BMP2K—connective tissue—periodontitis	0.00219	0.00565	CbGeAlD
Bosutinib—MAP2K1—epithelium—periodontitis	0.00216	0.00558	CbGeAlD
Bosutinib—SLK—trigeminal ganglion—periodontitis	0.00215	0.00555	CbGeAlD
Bosutinib—EPHB4—trigeminal ganglion—periodontitis	0.00213	0.00551	CbGeAlD
Bosutinib—RPS6KB1—parotid gland—periodontitis	0.00213	0.0055	CbGeAlD
Bosutinib—PTK2B—connective tissue—periodontitis	0.00211	0.00546	CbGeAlD
Bosutinib—EPHA2—trigeminal ganglion—periodontitis	0.00209	0.00541	CbGeAlD
Bosutinib—FYN—trigeminal ganglion—periodontitis	0.00209	0.0054	CbGeAlD
Bosutinib—SIK1—connective tissue—periodontitis	0.00205	0.00529	CbGeAlD
Bosutinib—MAP4K5—trigeminal ganglion—periodontitis	0.00204	0.00528	CbGeAlD
Bosutinib—MAP3K3—trigeminal ganglion—periodontitis	0.00204	0.00528	CbGeAlD
Bosutinib—SLK—parotid gland—periodontitis	0.00203	0.00524	CbGeAlD
Bosutinib—EPHB4—parotid gland—periodontitis	0.00201	0.0052	CbGeAlD
Bosutinib—ERBB3—connective tissue—periodontitis	0.00201	0.00518	CbGeAlD
Bosutinib—MAP3K2—connective tissue—periodontitis	0.00199	0.00513	CbGeAlD
Bosutinib—EPHA2—parotid gland—periodontitis	0.00198	0.0051	CbGeAlD
Bosutinib—PTK2—connective tissue—periodontitis	0.00195	0.00503	CbGeAlD
Bosutinib—MAP4K5—parotid gland—periodontitis	0.00193	0.00498	CbGeAlD
Bosutinib—MAP3K3—parotid gland—periodontitis	0.00193	0.00498	CbGeAlD
Bosutinib—ERBB3—epithelium—periodontitis	0.00191	0.00492	CbGeAlD
Bosutinib—YES1—trigeminal ganglion—periodontitis	0.00189	0.00487	CbGeAlD
Bosutinib—RPS6KB1—connective tissue—periodontitis	0.00187	0.00484	CbGeAlD
Bosutinib—STK10—trigeminal ganglion—periodontitis	0.00187	0.00483	CbGeAlD
Bosutinib—TAOK3—trigeminal ganglion—periodontitis	0.00186	0.00481	CbGeAlD
Bosutinib—AXL—connective tissue—periodontitis	0.00185	0.00479	CbGeAlD
Bosutinib—PTK2—epithelium—periodontitis	0.00185	0.00477	CbGeAlD
Bosutinib—YES1—parotid gland—periodontitis	0.00178	0.0046	CbGeAlD
Bosutinib—RPS6KB1—epithelium—periodontitis	0.00178	0.00459	CbGeAlD
Bosutinib—EPHB4—connective tissue—periodontitis	0.00177	0.00458	CbGeAlD
Bosutinib—TAOK3—parotid gland—periodontitis	0.00176	0.00454	CbGeAlD
Bosutinib—FYN—connective tissue—periodontitis	0.00174	0.00448	CbGeAlD
Bosutinib—EPHB4—epithelium—periodontitis	0.00168	0.00434	CbGeAlD
Bosutinib—PDGFRB—neck—periodontitis	0.00167	0.00432	CbGeAlD
Bosutinib—MAP2K5—trigeminal ganglion—periodontitis	0.00167	0.00431	CbGeAlD
Bosutinib—EPHA2—epithelium—periodontitis	0.00165	0.00426	CbGeAlD
Bosutinib—CSF1R—trigeminal ganglion—periodontitis	0.00163	0.00421	CbGeAlD
Bosutinib—MAP2K5—parotid gland—periodontitis	0.00157	0.00407	CbGeAlD
Bosutinib—YES1—connective tissue—periodontitis	0.00157	0.00404	CbGeAlD
Bosutinib—TAOK3—connective tissue—periodontitis	0.00155	0.00399	CbGeAlD
Bosutinib—SRC—connective tissue—periodontitis	0.00151	0.00389	CbGeAlD
Bosutinib—PDGFRB—trigeminal ganglion—periodontitis	0.00145	0.00373	CbGeAlD
Bosutinib—SRC—epithelium—periodontitis	0.00143	0.00369	CbGeAlD
Bosutinib—PDGFRB—parotid gland—periodontitis	0.00136	0.00352	CbGeAlD
Bosutinib—CSF1R—connective tissue—periodontitis	0.00135	0.00349	CbGeAlD
Bosutinib—ABL1—trigeminal ganglion—periodontitis	0.00129	0.00333	CbGeAlD
Bosutinib—ABL1—parotid gland—periodontitis	0.00121	0.00314	CbGeAlD
Bosutinib—PDGFRB—connective tissue—periodontitis	0.0012	0.0031	CbGeAlD
Bosutinib—PDGFRB—epithelium—periodontitis	0.00114	0.00294	CbGeAlD
Bosutinib—ABL1—connective tissue—periodontitis	0.00107	0.00276	CbGeAlD
Bosutinib—ABCB1—trigeminal ganglion—periodontitis	0.000401	0.00103	CbGeAlD
Bosutinib—ABCB1—epithelium—periodontitis	0.000316	0.000815	CbGeAlD
Bosutinib—ROCK1—Signaling Pathways—FGF2—periodontitis	1.4e-05	2.28e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—TLR4—periodontitis	1.39e-05	2.26e-05	CbGpPWpGaD
Bosutinib—TBK1—Immune System—IL6—periodontitis	1.39e-05	2.26e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCR2—periodontitis	1.38e-05	2.26e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—ADRB1—periodontitis	1.38e-05	2.25e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—FGF2—periodontitis	1.37e-05	2.24e-05	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—TGFB1—periodontitis	1.37e-05	2.24e-05	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—TGFB1—periodontitis	1.37e-05	2.24e-05	CbGpPWpGaD
Bosutinib—ERBB4—Disease—TGFB1—periodontitis	1.37e-05	2.24e-05	CbGpPWpGaD
Bosutinib—CAMK2G—Immune System—IL6—periodontitis	1.36e-05	2.22e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—CCL2—periodontitis	1.35e-05	2.21e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—MMP9—periodontitis	1.35e-05	2.2e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—FGF2—periodontitis	1.35e-05	2.2e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—FGF2—periodontitis	1.35e-05	2.2e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—FGF2—periodontitis	1.34e-05	2.19e-05	CbGpPWpGaD
Bosutinib—LCK—Hemostasis—TGFB1—periodontitis	1.34e-05	2.18e-05	CbGpPWpGaD
Bosutinib—MAP3K3—Immune System—IL6—periodontitis	1.33e-05	2.17e-05	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—TGFB1—periodontitis	1.33e-05	2.17e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Innate Immune System—IL6—periodontitis	1.33e-05	2.17e-05	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—TNF—periodontitis	1.32e-05	2.16e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—NTRK1—periodontitis	1.32e-05	2.16e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—IL1B—periodontitis	1.32e-05	2.15e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—CXCL8—periodontitis	1.32e-05	2.15e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—FGF2—periodontitis	1.31e-05	2.14e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Developmental Biology—IL6—periodontitis	1.31e-05	2.14e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—FGF2—periodontitis	1.31e-05	2.13e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—FGF2—periodontitis	1.3e-05	2.12e-05	CbGpPWpGaD
Bosutinib—BTK—Immune System—IL6—periodontitis	1.29e-05	2.11e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—IFNG—periodontitis	1.29e-05	2.11e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—FGF2—periodontitis	1.29e-05	2.11e-05	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—PPARA—periodontitis	1.29e-05	2.11e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—CXCL8—periodontitis	1.29e-05	2.1e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—FGF2—periodontitis	1.29e-05	2.1e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CRP—periodontitis	1.28e-05	2.09e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—CCL2—periodontitis	1.28e-05	2.08e-05	CbGpPWpGaD
Bosutinib—SRC—Axon guidance—IL6—periodontitis	1.28e-05	2.08e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—NTRK1—periodontitis	1.27e-05	2.08e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—FGF2—periodontitis	1.27e-05	2.07e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—CXCL8—periodontitis	1.27e-05	2.07e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—NOS2—periodontitis	1.26e-05	2.06e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IFNG—periodontitis	1.26e-05	2.06e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—CCL2—periodontitis	1.26e-05	2.06e-05	CbGpPWpGaD
Bosutinib—LYN—Developmental Biology—IL6—periodontitis	1.25e-05	2.05e-05	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—IL6—periodontitis	1.25e-05	2.04e-05	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—IL6—periodontitis	1.24e-05	2.02e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—FGF2—periodontitis	1.24e-05	2.02e-05	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—IL6—periodontitis	1.24e-05	2.02e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—IFNG—periodontitis	1.24e-05	2.02e-05	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—IL6—periodontitis	1.23e-05	2.02e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—CXCL8—periodontitis	1.23e-05	2.01e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IFNG—periodontitis	1.23e-05	2.01e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—TLR4—periodontitis	1.23e-05	2.01e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MMP3—periodontitis	1.23e-05	2.01e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—IL6—periodontitis	1.23e-05	2e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—CXCL8—periodontitis	1.22e-05	1.99e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—NOS2—periodontitis	1.22e-05	1.99e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—IFNG—periodontitis	1.22e-05	1.98e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IFNG—periodontitis	1.21e-05	1.97e-05	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—TGFB1—periodontitis	1.21e-05	1.97e-05	CbGpPWpGaD
Bosutinib—ERBB3—Disease—TGFB1—periodontitis	1.21e-05	1.97e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—CCL2—periodontitis	1.19e-05	1.95e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—IL6—periodontitis	1.19e-05	1.95e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—FGF2—periodontitis	1.19e-05	1.95e-05	CbGpPWpGaD
Bosutinib—HCK—Immune System—IL6—periodontitis	1.19e-05	1.94e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—FGF2—periodontitis	1.19e-05	1.94e-05	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—TGFB1—periodontitis	1.18e-05	1.93e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MMP3—periodontitis	1.18e-05	1.93e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—CXCL8—periodontitis	1.18e-05	1.92e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—CXCL8—periodontitis	1.18e-05	1.92e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—MMP9—periodontitis	1.16e-05	1.9e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling by GPCR—IL6—periodontitis	1.16e-05	1.9e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Innate Immune System—IL6—periodontitis	1.16e-05	1.89e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—FGF2—periodontitis	1.15e-05	1.88e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—IL1B—periodontitis	1.15e-05	1.88e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—MMP9—periodontitis	1.15e-05	1.87e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—PTGS2—periodontitis	1.14e-05	1.87e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—FGF2—periodontitis	1.14e-05	1.86e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—CXCL8—periodontitis	1.13e-05	1.85e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Innate Immune System—IL6—periodontitis	1.13e-05	1.85e-05	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—TNF—periodontitis	1.13e-05	1.84e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NTRK1—periodontitis	1.13e-05	1.84e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IL1B—periodontitis	1.13e-05	1.84e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CCL2—periodontitis	1.13e-05	1.84e-05	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—IL6—periodontitis	1.12e-05	1.82e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—PTGS2—periodontitis	1.12e-05	1.82e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—FGF2—periodontitis	1.12e-05	1.82e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—TGFB1—periodontitis	1.11e-05	1.81e-05	CbGpPWpGaD
Bosutinib—LYN—Innate Immune System—IL6—periodontitis	1.11e-05	1.81e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—MMP9—periodontitis	1.11e-05	1.8e-05	CbGpPWpGaD
Bosutinib—ABL1—Innate Immune System—IL6—periodontitis	1.1e-05	1.8e-05	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—IL6—periodontitis	1.1e-05	1.8e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—IL1B—periodontitis	1.1e-05	1.8e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IL1B—periodontitis	1.1e-05	1.79e-05	CbGpPWpGaD
Bosutinib—HCK—Disease—IL6—periodontitis	1.1e-05	1.79e-05	CbGpPWpGaD
Bosutinib—FYN—Innate Immune System—IL6—periodontitis	1.09e-05	1.78e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—IL1B—periodontitis	1.08e-05	1.77e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Innate Immune System—IL6—periodontitis	1.08e-05	1.77e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—FGF2—periodontitis	1.08e-05	1.76e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—NOS2—periodontitis	1.08e-05	1.76e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IL1B—periodontitis	1.08e-05	1.76e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—PTGS2—periodontitis	1.08e-05	1.76e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—FGF2—periodontitis	1.08e-05	1.76e-05	CbGpPWpGaD
Bosutinib—BLK—Immune System—IL6—periodontitis	1.08e-05	1.76e-05	CbGpPWpGaD
Bosutinib—FGR—Immune System—IL6—periodontitis	1.07e-05	1.75e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—PTGS2—periodontitis	1.07e-05	1.75e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—CXCL8—periodontitis	1.07e-05	1.74e-05	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—IL6—periodontitis	1.07e-05	1.74e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—MMP9—periodontitis	1.06e-05	1.74e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—MMP9—periodontitis	1.06e-05	1.74e-05	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—IL6—periodontitis	1.05e-05	1.72e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IFNG—periodontitis	1.05e-05	1.71e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MMP3—periodontitis	1.05e-05	1.71e-05	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—IL6—periodontitis	1.04e-05	1.69e-05	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—IL6—periodontitis	1.04e-05	1.69e-05	CbGpPWpGaD
Bosutinib—ERBB4—Disease—IL6—periodontitis	1.03e-05	1.68e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—FGF2—periodontitis	1.03e-05	1.68e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—MMP9—periodontitis	1.03e-05	1.67e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—FGF2—periodontitis	1.02e-05	1.66e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—IFNG—periodontitis	1.01e-05	1.65e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—CXCL8—periodontitis	1.01e-05	1.65e-05	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—IL6—periodontitis	1e-05	1.63e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—CXCL8—periodontitis	9.96e-06	1.63e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—FGF2—periodontitis	9.94e-06	1.62e-05	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—IL6—periodontitis	9.86e-06	1.61e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CCL2—periodontitis	9.83e-06	1.6e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—TGFB1—periodontitis	9.59e-06	1.57e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CCL2—periodontitis	9.59e-06	1.57e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—FGF2—periodontitis	9.53e-06	1.55e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—TGFB1—periodontitis	9.46e-06	1.54e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—CXCL8—periodontitis	9.45e-06	1.54e-05	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—IL6—periodontitis	9.42e-06	1.54e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CCL2—periodontitis	9.39e-06	1.53e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL1B—periodontitis	9.37e-06	1.53e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ACP5—periodontitis	9.36e-06	1.53e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—PTGS2—periodontitis	9.3e-06	1.52e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CCL2—periodontitis	9.25e-06	1.51e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CCL2—periodontitis	9.2e-06	1.5e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—MMP9—periodontitis	9.13e-06	1.49e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—TGFB1—periodontitis	9.11e-06	1.49e-05	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—IL6—periodontitis	9.1e-06	1.49e-05	CbGpPWpGaD
Bosutinib—ERBB3—Disease—IL6—periodontitis	9.1e-06	1.49e-05	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—IL6—periodontitis	9.08e-06	1.48e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL1B—periodontitis	9.03e-06	1.47e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—MMP9—periodontitis	9.01e-06	1.47e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—IFNG—periodontitis	8.96e-06	1.46e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—PTGS2—periodontitis	8.96e-06	1.46e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CXCL8—periodontitis	8.89e-06	1.45e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—FGF2—periodontitis	8.89e-06	1.45e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—FGF2—periodontitis	8.8e-06	1.44e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—TGFB1—periodontitis	8.77e-06	1.43e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—TGFB1—periodontitis	8.77e-06	1.43e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—IL6—periodontitis	8.77e-06	1.43e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—FGF2—periodontitis	8.67e-06	1.41e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—IL6—periodontitis	8.65e-06	1.41e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—MMP9—periodontitis	8.54e-06	1.39e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—FGF2—periodontitis	8.49e-06	1.39e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—TGFB1—periodontitis	8.46e-06	1.38e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GGT1—periodontitis	8.45e-06	1.38e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—IL6—periodontitis	8.36e-06	1.36e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—FGF2—periodontitis	8.36e-06	1.36e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—FGF2—periodontitis	8.31e-06	1.36e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—TGFB1—periodontitis	8.27e-06	1.35e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—IL6—periodontitis	8.21e-06	1.34e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—TGFB1—periodontitis	8.07e-06	1.32e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—MMP9—periodontitis	8.04e-06	1.31e-05	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—IL6—periodontitis	8.04e-06	1.31e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL1B—periodontitis	8e-06	1.3e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CCL2—periodontitis	7.99e-06	1.3e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—PTGS2—periodontitis	7.93e-06	1.29e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—TGFB1—periodontitis	7.78e-06	1.27e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CXCL8—periodontitis	7.77e-06	1.27e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—TGFB1—periodontitis	7.74e-06	1.26e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—IL6—periodontitis	7.73e-06	1.26e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CCL2—periodontitis	7.7e-06	1.26e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CXCL8—periodontitis	7.59e-06	1.24e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—TGFB1—periodontitis	7.53e-06	1.23e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CXCL8—periodontitis	7.43e-06	1.21e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—TGFB1—periodontitis	7.42e-06	1.21e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—IL6—periodontitis	7.39e-06	1.21e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CXCL8—periodontitis	7.31e-06	1.19e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CXCL8—periodontitis	7.27e-06	1.19e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—IL6—periodontitis	7.23e-06	1.18e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—FGF2—periodontitis	7.22e-06	1.18e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—IL6—periodontitis	7.13e-06	1.16e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—TGFB1—periodontitis	7.04e-06	1.15e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—MMP9—periodontitis	7.03e-06	1.15e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—FGF2—periodontitis	6.96e-06	1.14e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—IL6—periodontitis	6.92e-06	1.13e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—IL6—periodontitis	6.86e-06	1.12e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—MMP9—periodontitis	6.86e-06	1.12e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCL2—periodontitis	6.82e-06	1.11e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—IL6—periodontitis	6.75e-06	1.1e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—TGFB1—periodontitis	6.72e-06	1.1e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—MMP9—periodontitis	6.72e-06	1.1e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TGFB1—periodontitis	6.63e-06	1.08e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—MMP9—periodontitis	6.61e-06	1.08e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—IL6—periodontitis	6.61e-06	1.08e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—IL6—periodontitis	6.61e-06	1.08e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IL6—periodontitis	6.59e-06	1.08e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—MMP9—periodontitis	6.58e-06	1.07e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—TGFB1—periodontitis	6.48e-06	1.06e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—IL6—periodontitis	6.45e-06	1.05e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IL6—periodontitis	6.42e-06	1.05e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—IL6—periodontitis	6.37e-06	1.04e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—IL6—periodontitis	6.35e-06	1.04e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IL6—periodontitis	6.32e-06	1.03e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CXCL8—periodontitis	6.32e-06	1.03e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—IL6—periodontitis	6.24e-06	1.02e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—FGF2—periodontitis	6.16e-06	1.01e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CXCL8—periodontitis	6.09e-06	9.93e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—IL6—periodontitis	6.08e-06	9.93e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PPARA—periodontitis	6.05e-06	9.87e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—IL6—periodontitis	6.01e-06	9.8e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—IL6—periodontitis	5.86e-06	9.57e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—IL6—periodontitis	5.83e-06	9.52e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TGFB1—periodontitis	5.79e-06	9.46e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—TGFB1—periodontitis	5.74e-06	9.36e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MMP9—periodontitis	5.71e-06	9.32e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—IL6—periodontitis	5.67e-06	9.26e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TGFB1—periodontitis	5.65e-06	9.23e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—IL6—periodontitis	5.59e-06	9.13e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TGFB1—periodontitis	5.54e-06	9.03e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MMP9—periodontitis	5.51e-06	8.98e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL6—periodontitis	5.49e-06	8.96e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TGFB1—periodontitis	5.45e-06	8.89e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TGFB1—periodontitis	5.42e-06	8.85e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CXCL8—periodontitis	5.39e-06	8.79e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—IL6—periodontitis	5.31e-06	8.66e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL6—periodontitis	5.29e-06	8.63e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GGT1—periodontitis	5.2e-06	8.49e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—IL6—periodontitis	5.07e-06	8.27e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL6—periodontitis	5e-06	8.15e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—IL6—periodontitis	4.88e-06	7.97e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MMP9—periodontitis	4.87e-06	7.95e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TGFB1—periodontitis	4.71e-06	7.68e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL6—periodontitis	4.68e-06	7.64e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TGFB1—periodontitis	4.54e-06	7.4e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL6—periodontitis	4.37e-06	7.12e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—IL6—periodontitis	4.32e-06	7.05e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL6—periodontitis	4.26e-06	6.95e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL6—periodontitis	4.17e-06	6.81e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL6—periodontitis	4.11e-06	6.7e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL6—periodontitis	4.09e-06	6.67e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TGFB1—periodontitis	4.02e-06	6.56e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PTGS2—periodontitis	3.93e-06	6.42e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PPARA—periodontitis	3.73e-06	6.08e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL6—periodontitis	3.55e-06	5.79e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL6—periodontitis	3.42e-06	5.58e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL6—periodontitis	3.03e-06	4.94e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PTGS2—periodontitis	2.42e-06	3.95e-06	CbGpPWpGaD
